Zoetic International commences trading on the OTCQX and inclusion in the MSCI Microcap Index

Zoetic International plc (LON:ZOE) has announced that its ordinary shares are now trading on the OTCQX® Best Market in the U.S., under the ticker symbol ZOEIF.  The OTCQX® Best Market is the highest level of the OTC markets.  Zoetic upgraded to OTCQX from the OTCQB® Venture Market.

The OTCQX Market is designed for established, investor-focused U.S. and international companies.  To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.  Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.

Zoetic’s ordinary shares will continue to trade on the London Stock Exchange under the symbol ZOE. 

In addition to the benefits of the OTCQX Market, the Company is currently evaluating additional opportunities to improve investor relations and communications in North America.  The Zoetic directors believe the Company represents a unique opportunity for investors to access a company that is disrupting the tobacco industry with high quality CBD products on an international distribution platform. 

In addition to OTCQX trading, the Company is also pleased to announce that it recently has been included in the MSCI Microcap Index.  Inclusion in the index reflects the Company’s recent progress in transitioning to a pure play, integrated CBD company and the resultant increase in market capitalisation. The inclusion in the index is another step towards increasing Zoetic’s stock liquidity and investment profile in the U.S.

Trevor Taylor, Co-CEO of Zoetic, commented, “The combination of trading on OTCQX and index inclusion reflect the Company’s tremendous progress towards transitioning to a pure play, integrated CBD company over the past 12 months.  Our recent product development and wholesale distribution expansion have set the stage for the first leg of projected multi-year, sustainable growth for the Company.  We couldn’t be more pleased with our progress to date, as well as our current position in this high-growth market.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    DirectorsTalk

    More articles like this

    Zoetic International plc

    Zoetic International changes name to Chill Brands Group

    Zoetic International plc (LON:ZOE), the international CBD group, has announce that the name of the Company has now been changed at Companies House to Chill Brands Group plc. The Company will make a further announcement when it

    Zoetic International plc

    Zoetic International sees significant traction in sales of CBD products

    Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has announced its interim results for the six months ended 30 September 2020. Highlights ·  Transition from legacy natural resources business to vertically integrated CBD company substantially

    Zoetic International plc

    Zoetic International investor presentation 29th October 2020

    Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has announced that its 2020 Annual General Meeting will be held on Wednesday, 28 October 2020, at 3pm (GMT). In connection with the AGM, the Notice

    Zoetic International plc

    Zoetic International exits from the oil and gas business

    Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has announced that it has agreed to sell its remaining interest in its oil and gas assets located in Colorado, USA, as well as continued progress

    Zoetic International plc

    Q&A: Zoetic International “A very bright future” (LON:ZOE)

    Zoetic International’s Trevor Taylor discuss their partnership with GVB Biopharma, termination of the lease on its Colorado greenhouse facility, new agreement with a European cultivation partner and the focus for the company in this exclusive interview with DirectorsTalk.